2020
DOI: 10.5125/jkaoms.2020.46.1.19
|View full text |Cite
|
Sign up to set email alerts
|

The effects of pentoxifylline and tocopherol in jaw osteomyelitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
16
0
8

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 30 publications
(24 citation statements)
references
References 22 publications
0
16
0
8
Order By: Relevance
“…Depending on its location and extent, symptoms may include pain, bad breath, dysgeusia, numbness, trismus, mastication and speech difficulties, fistula, pathologic fractures, and local, spreading, or systemic infection. Osteoradionecrosis is a lifelong risk for those who have received high-dose radiation [16].…”
Section: Osteoradionecrosismentioning
confidence: 99%
See 1 more Smart Citation
“…Depending on its location and extent, symptoms may include pain, bad breath, dysgeusia, numbness, trismus, mastication and speech difficulties, fistula, pathologic fractures, and local, spreading, or systemic infection. Osteoradionecrosis is a lifelong risk for those who have received high-dose radiation [16].…”
Section: Osteoradionecrosismentioning
confidence: 99%
“…Tooth extraction and dental disease in irradiated areas are major contributors to osteoradionecrosis. It may be necessary to remove decayed teeth before RT if they are in the area receiving RT [16]. Ideally, at least 7 to 14 days should be allowed for healing before initiation of RT; some have suggested allowing up to 21 days.…”
Section: Osteoradionecrosismentioning
confidence: 99%
“…Each patient's singular and clinical specifications must be considered in order to optimize the benefits of treatment. Currently, newly updated paradigms for conservative treatment such as medication with pentoxifylline and tocopherol are being clinically accepted 2 .…”
mentioning
confidence: 99%
“…The use of PENTO seems to be a promising alternative, but all systematic reviews and meta-analysis show the need for further prospective clinical trials using PENTO in the treatment of ORN; therefore, the evidence remains insufficient to determine its treatment protocol for ORN 3 . The study cited by the authors used PENTO as a treatment for diseases with different etiopathogenesis as ORN and osteonecrosis of the jaws related to medications 4 . We do not understand how it is not possible to analyze the results of PENTO treatment of bone necrosis of different diseases included in the same group.…”
mentioning
confidence: 99%
“…Two relevant points after a careful reading of the brief communication are that the article by these authors who used PENTO as a conservative treatment showed a serious error when they included bone necrosis of different etiopathogenesis in the same group 4 . Treatment with PENTO is one of the conservative treatment options as implicit in our study.…”
mentioning
confidence: 99%